Literature DB >> 29099467

Genotype-Phenotype Associations of APC Mutations With Pouch Adenoma in Patients With Familial Adenomatous Polyposis.

Revital Kariv1,2, Guy Rosner1,2, Naomi Fliss-Isakov1,2, Nathan Gluck1,2, Adam Goldstein2,3, Hagit Tulchinsky2,3, Shira Zelber-Sagi1,4.   

Abstract

BACKGROUND: Patients with familial adenomatous polyposis (FAP) may carry various adenomatous polyposis coli (APC) mutations. However, genotype-phenotype correlation for APC mutations is still debated and is yet to be evaluated with regard to pouch polyp formation.
OBJECTIVE: To evaluate the association between APC mutation type and exon location and the outcome of pouch adenoma. DESIGN SETTING AND PATIENTS: Forty-five FAP patients with defined pathogenic APC mutations, who underwent total proctocolectomy and ileal pouch anal anastomosis were classified by mutation type and location. Analysis was conducted for clinical and endoscopic parameters.
RESULTS: Twenty patients had either indel/deletion mutations and 25 had nonsense/missense mutations. The indel/deletion group was associated with higher prevalence of preoperative hundreds of colonic adenomas (66.7% vs. 30%; P=0.030), lower rates of stapled versus sewn anastomosis (46.7% vs. 76%; P=0.060), of single stage surgery (13.3% vs. 44%; P=0.045) and with higher pouch adenoma formation rate (50% vs. 8%; P=0.002). Twenty-seven were carriers of exons 1 to 14 mutations and 18 were carriers of exon 15 mutations. Carriers of exon 15 mutations had higher prevalence of preoperative hundreds of colonic adenomas (55.6% vs. 22.2%; P=0.003) and a higher tendency for pouch and cuff adenoma formation rate. Adjusted odds ratio for pouch adenoma formation was 8.32 (1.42-48.80; P=0.019) for the indel/deletion group versus nonsense/missense, but no significant independent association was noted with mutation location. The mean number of pouch and cuff adenoma formation (per endoscopy) was higher among carriers of exon 15 mutations, but no significant independent association was noted the with mutation type.
CONCLUSIONS: Type and location of APC mutation are associated with colonic polyp burden, surgical outcome and likelihood of developing pouch adenomas. These findings may contribute to surgical and endoscopic surveillance decisions for FAP patients.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29099467     DOI: 10.1097/MCG.0000000000000950

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis.

Authors:  Masahiro Tajika; Tsutomu Tanaka; Makoto Ishihara; Yutaka Hirayama; Sachiyo Oonishi; Nobumasa Mizuno; Takamichi Kuwahara; Nozomi Okuno; Shinpei Matsumoto; Taihei Ooshiro; Takashi Kinoshita; Koji Komori; Vikram Bhatia; Kazuo Hara; Yasushi Yatabe; Yasumasa Niwa
Journal:  Endosc Int Open       Date:  2019-05-08

2.  Heterozygous APC germline mutations impart predisposition to colorectal cancer.

Authors:  Livia Preisler; Aline Habib; Guy Shapira; Liron Kuznitsov-Yanovsky; Yoav Mayshar; Ilana Carmel-Gross; Mira Malcov; Foad Azem; Noam Shomron; Revital Kariv; Dov Hershkovitz; Dalit Ben-Yosef
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 3.  Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

Authors:  Guillaume Le Cosquer; Etienne Buscail; Cyrielle Gilletta; Céline Deraison; Jean-Pierre Duffas; Barbara Bournet; Géraud Tuyeras; Nathalie Vergnolle; Louis Buscail
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

4.  Cumulative incidence and risk factors for pouch adenomas associated with familial adenomatous polyposis following restorative proctocolectomy.

Authors:  Hyo Seon Ryu; Chang Sik Yu; Young Il Kim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim
Journal:  World J Gastroenterol       Date:  2022-08-14       Impact factor: 5.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.